ResMed Inc: chairman and CEO Farrell Michael J. exercised 4,991 shares

What happened

• Farrell Michael J., chairman and CEO and director, exercised options for 4,991 shares at $146.34 on Oct 07, 2026, for $730,383 and the filing shows a derivative disposition at $0.00 related to the exercise. The filing also reports an open-market sale of 4,991 shares at a weighted average price of $226.33 on Oct 07, 2026, for $1,129,637.

Key details

• Transaction date: Oct 07, 2026; filing date: Oct 08, 2026.
• Exercise price: $146.34 for 4,991 shares (total $730,383).
• Sale: 4,991 shares at a weighted average price of $226.33 (total $1,129,637); sale executed in multiple trades at prices ranging from $222.2135 to $227.581.
• Derivative disposition: reported at $0.00 in the filing.
• Footnotes: transaction executed under a Rule 10b5-1 plan adopted Oct 31, 2024; sale prices executed across multiple trades (see range above); F3 notes represent date options first become exercisable and that options vest 1/3 per year.
• Shares owned after the transaction: the filing does not report shares owned following the reported transactions.

Why it may matter

• The filing shows an option exercise followed by an immediate sale of the same number of shares on the same day (cashless exercise pattern in the filing).
• The sale was executed in multiple trades at a reported weighted average price.
• This filing does not show why the insider traded or why the company acted.